Cellular mechanisms in sympatho-modulation of the heart

British Journal of Anaesthesia

Volumn 93, Issue 1, 2004, Pages 34-52

  Zaugg, Michael ^a   Schaub, C ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adrenergic receptor signalling; Calcium, signalling; MAPK signalling; Muscle, vascular smooth muscle regulation; Myocardial contractility

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENYLATE CYCLASE; ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM ION; CELL SURFACE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR SUBTYPE;

ADAPTATION; ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; BLOOD VESSEL TONE; CALCIUM SIGNALING; CARDIOVASCULAR FUNCTION; CELL ACTIVITY; CELL GROWTH; CELL METABOLISM; CHOLINERGIC SYSTEM; ENZYME INHIBITION; EXCITATION CONTRACTION COUPLING; FEEDBACK SYSTEM; GENE EXPRESSION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RATE; HUMAN; MOLECULAR MECHANICS; MUSCLE FIBER CONTRACTION; NEGATIVE FEEDBACK; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; STARLING LAW; SURGICAL INJURY; SYMPATHETIC TONE; TARGET CELL; VASCULAR SMOOTH MUSCLE;

EID: 3242754326     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh159     Document Type: Article

References (100)

1. Andersen GO, Qvigstad E, Schiander I, Aass H, Osnes JB, Skomedal T. Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am J Physiol 2002; 283: H1471-80
2. Andrews KL, Triggle CR, Ellis A. NO and the vasculature: where does it come from and what does it do? Heart Fail Rev 2002; 7: 423-45
3. Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G-protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42: 409-35
4. 2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure. Trends Cardiovasc Med 2003; 13: 152-7
5. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCE and MAPK form signaling modules in the murine heart. Enhanced mitochondrial PKCE-MAPK interactions and differential MAPK activation in PKCE-induced cardioprotecti on. Circ Res 2002; 90: 390-7
6. Barreiro G, Guimaraes CRW, de Alencastro RB. A molecular dynamics study of an L-type calcium channels model. Protein Eng 2002; 15: 109-22
7. Berridge MJ. Elementary and global aspects of calcium signalling. J Exp Biol 1997; 200: 315-9
8. Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205
9. Biel M, Ludwig A, Zong X, Hofmann F. Hyperpolarization-activated cation channels: a multigene family. Rev Physiol giochem Pharmacol 1999; 136: 165-81
10. Bowles DK, Wamhoff BR. Coronary smooth muscle adaptation to exercise: does it play a role in cardioprotection? Acta Physiol Scand 2003; 178: 117-21
11. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51: 651-89
12. Bünemann M, Lee KB, Pals-Rylaarsdam R, Roseberry AG, Hosey MM. Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu Rev Physiol 1999; 61: 169-92
13. Canaves JM, Taylor SS. Classification and phylogenetic analysis of the cAMP-dependent protein kinase regulatory subunit family. J Mol Evol 2002; 54: 17-29
14. Carafoli E. Calcium signaling: a tale for all seasons. Proc Natl Acad Sci USA 2002; 99: 1115-22
15. 2+ sensitivity. J Gen Physiol 2000; 116: 411-32
16. 2+ release mechanisms: multiple pathways having multiple functions within the same cell type? Biochim Biophys Acta 2000; 1498: 122-33
17. Eckert RE, Karsten AJ, Utz J, Ziegler M. Regulation of renal artery smooth muscle tone by α1-adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores. Urol Res 2000; 28: 122-7
18. 2+ channels. Trends Pharmacol Sci 1997; 18: 37-42
19. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 2003; 177: 275-84
20. Esposito G, Rapacciuolo A, Naga Prasad SV, Rockman HA. Cardiac hypertrophy: role of G protein-coupled receptors. J Cardiac Fail 2002; 8 (Suppl. 6): S409-14
21. Ferguson SSG. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53: 1-24
22. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 2003; 57: 20-7
23. Fukuda N, Sasaki D, Ishiwata S, Kurihara S. Length dependence of tension generation in rat skinned cardiac muscle. Circ Res 2001; 104: 1639-45
24. 2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies. J Hypertens 2001; 19: 2115-24
25. Georget M, Mateo P, Vandecasteele G, et al. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type-8 (AC8). FASEB J 2003; 17: 1380-91
26. 2+ current in single frog ventricular myocytes. J Physiol (London) 2001; 530: 79-91
27. Gomes AV, Potter JD, Szczesna-Cordary D. The role of troponins in muscle contraction. IUBMB Life 2002; 54: 323-33
28. 2-AR in myocytes from failing human heart. Circulation 2002; 105: 2497-503
29. 2+ bind to the catalytic domain, but not the C2 domain. Biochemistry 1998; 37: 5020-8
30. Hall RA, Lefkowitz RJ. Regulation of G-protein-coupled receptor signaling by scaffold proteins. Circ Res 2002; 91: 672-80
31. Han JL, Zhang YY, Lu ZZ, Mao JM, Chen MZ, Han QD. Functional α1-adrenergic receptor subtypes in human right gastroepiploic artery. Acta Pharmacol Sin 2003; 24: 327-31
32. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 1999; 99: 641-8
33. Hefti MA, Harder BA, Eppenberger HM, Schaub MC. Signaling pathways in cardiac hypertrophy. J Mol Cell Cardiol 1997; 29: 2873-92
34. 2+ channels. J Physiol (London) 2000; 528: 237-49
35. Houslay MD, Adams DR. PDE4 cAMP phosphodiesterase: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 2003; 370: 1-18
36. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002; 91: 877-87
37. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-2
38. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001; 276: 4527-30
39. Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 2002; 87: 1095-102
40. Kaupp UB, Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 2001; 63: 235-57
41. 2+ channels (Cav1.2a,b) by protein kinases. Am J Physiol 2001; 281: C1743-56
42. Koch WJ. Gene transfer of β-adrenergic signaling components for heart failure. J Cardiac Fail 2002; 8 (Suppl. 6): S526-31
43. 1-adrenoceptor pharmacology. Pharmacol Ther 2003; 98: 235-44
44. Krebs J. Calmodulin-dependent protein kinases. In: Carafoli E, Krebs J, eds. Calcium Homeostasis. Berlin: Springer, 2000; 201-123
45. Kristensen B, Birkelund S, Jorgensen PL. Trafficking of Na, K-ATPase fused to enhanced green fluorescent protein is mediated by protein kinase A or C. J Membr Biol 2003; 191: 25-36
46. 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 2002; 277: 35402-10
47. Lincoln TM, Dey N, Sellak H. cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 2001; 91: 1421-30
48. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Cell Biol 2003; 4: 566-77
49. Marks AR. Cardiac intracellular calcium release channels. Role in heart failure. Circ Res 2000; 87: 8-11
50. Marston S, Burton D, Copeland O, et al. Structural interactions between actin, tropomyosin, caldesmon and calcium binding protein and the regulation of smooth muscle thin filaments. Acta Physiol Scand 1998; 164: 401-14
51. Marston SB, Redwood CS. Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins. Physiological and pathological implications. Circ Res 2003; 93: 1170-8
52. Maurice DH, Palmer D, Tilley DG, et al. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 2003; 64: 533-46
53. Michel MC, Li Y, Heusch G. Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 245-66
54. Michelotti GA, Price DT, Schwinn DA. Alpha1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 2000; 88: 281-309
55. Molkentin JD, Dorn GW. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63: 391-426
56. Moosmang S, Stieber J, Zong X, Biel M, Hofmann F, Ludwig A. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur J Biochem 2001; 268: 1646-52
57. Morano I. Tuning smooth muscle contraction by molecular motors. J Mol Med 2003; 81: 481-7
58. Murphy PA. What is special about smooth muscle? The significance of covalent crossbridge regulation. FASEB J 1994; 8: 311-18
59. Nakayama S, Kawasaki H, Kretsinger R. Evolution of EF-hand proteins. In: Carafoli E, Krebs J, eds. Calcium Homeostasis. Springer, 2000; 29-58
60. Neves S, Ram PT, Iyengar R. G-protein pathways. Science 2002; 296: 1636-9
61. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase-C as a paradigm. Biochem J 2003; 370: 361-71
62. 2+ exchanger. J Biol Chem 1999; 274: 910-7
63. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol 2004; 286: H468-76
64. Owuor ED, Kong ANT. Antioxidant and oxidant regulated signal transduction pathways. Biochem Pharmacol 2002; 64: 765-70
65. Patel TB, Du Z, Pierre S, Cartin L, Scholich K. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 2001; 269: 13-25
66. Perry SV. Troponin T: genetics, properties and function. J Muscle Res Cell Motil 1998; 19: 575-602
67. Perry SV. Troponin-I: inhibitor or facilitator. Mol Cell Biochem 1999; 190: 9-32
68. Peyton PJ, Myles PS, Silbert BS, et al. Perioperative epidural analgesia and outcome after major abdominal surgery in high risk patients. Anesth Analg 2003; 96: 548-54
69. 2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol 2002; 283: R287-95
70. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure. Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 2001; 88: 1159-67
71. Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 2001; 33: 887-905
72. Post SR, Hammond HK, Insel PA. β-adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 1999; 39: 343-60
73. Pouyssegur J, Volmat V, Lenormand P. Fidelity and spatiotemporal control in MAPK kinase (ERKs) signalling. Biochem Pharmacol 2002; 64: 755-63
74. Riemann B, Schäfers M, Law MP, Wichter T, Schober O. Radioligands for imaging myocardial α- and β-adrenoceptors. Nuklearmedizin 2003; 1: 4-9
75. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Cell Biol 2003; 4: 446-56
76. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002; 414: 206-12
77. Saimi Y, Kung C. Calmodulin as an ion channel subunit. Annu Rev Physiol 2002; 64: 289-311
78. Salahpour A, Angers S, Bouvier M. Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol Metab 2000; 11: 163-8
79. Schaub MC, Hefti MA, Zuellig RA, Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res 1998; 37: 381-404
80. 2-Adrenoceptor agonists in anaesthesia: a new paradigm. Curr Opin Anesthesiol 2000; 13: 437-42
81. Schubert R, Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci 2001; 22: 505-12
82. Schulze DH, Muqhal M, Lederer WJ, Ruknudin AM. Sodium/calcium exchanger (NCXI) macromolecular complex. J Biol Chem 2003; 278: 28849-55
83. Shakur Y, Fong M, Hensley J, et al. Comparison of the effects of Cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart. Cardiovasc Drug Ther 2002; 16: 417-27
84. Shin HM, Je HD, Gallant C, et al. Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 2002; 90: 546-53
85. Skalhegg B, Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 2000; 5: 678-93
86. 2+ sensitivity of smooth muscle and non-muscle myosin-II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-58
87. Steiberg SF, Brunton LL. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 2001; 41: 751-73
88. Striggow F, Ehrlich BE. Ligand-gated calcium channels inside and out. Curr Opin Cell Biol 1996; 8: 490-5
89. Swärd K, Mita M, Wilson DP, Deng JT, Susnjar M, Walsh MP. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertension Reports 2003; 5: 66-72
90. 3-adrenergic receptor. Cardiovasc Res 2003; 59: 288-96
91. 2+ ATPase. Proc Natl Acad Sci USA 2003; 100: 467-72
92. 1D-AR. Am J Physiol 2003; 284: H1104-9
93. 2+ current to protein kinase-A: role of calmodulin. Am J Physiol 2004; 286: H186-94
94. 2-adrenoceptor coupling to Gs-, Gi, and Gq-proteins. Mol Pharmacol 2000; 58: 954-66
95. Wier WG, Morgan KG. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Rev Physiol Biochem Pharmacol 2004; 150: 91-139
96. Xiang Y, Kobilka BK. Myocyte adrenoceptor signaling pathways. Science 2003; 300: 1530-2
97. 2-adrenergic receptor regulates its coupling to Gs and Gi. J Biol Chem 2002; 277: 31249-56
98. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-23
99. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003; 24: 219-49
100. Zylinska L, Kawecka I, Lachowicz L, Szemraj J. The isoform- and location-dependence of the functioning of the plasma membrane calcium pump. Cell Mol Biol Lett 2002; 7: 1037-45